ImmunoCellular Therapeutics (IMUC) Reports In-Line Q3 EPS

November 10, 2016 4:30 PM EST
Get Alerts IMUC Hot Sheet
Trade IMUC Now!
Join SI Premium – FREE

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

ImmunoCellular Therapeutics (NYSE: IMUC) reported Q3 EPS of ($0.04), in-line with the analyst estimate of ($0.04).

For earnings history and earnings-related data on ImmunoCellular Therapeutics (IMUC) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment